TWiV 817: COVID-19 clinical update #84 with Dr. Daniel Griffin

October 16, 2021

In COVID-19 clinical update #84, Dr. Griffin discusses childrens’ antibody response to vaccination, phase 3 results of Novavax vaccine, heterologous vaccination, antithrombotic therapy, EUA for molnupiravir, phase 3 results of AZD7442, serum ferritin levels and outcomes, heparin therapy, and WHO strategy for global vaccination.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 817 (30 MB .mp3, 50 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

One comment on “TWiV 817: COVID-19 clinical update #84 with Dr. Daniel Griffin

  1. Ian Light Oct 21, 2021

    Are there any clinical features or blood tests in the early viral phase such as a high fever above 38.5 C or high CRP or lymphopenia that indicate a likely deterioration to hospital admission or severe covid 19 in addition to the listed risk factors ?